UNRESECTABLE METASTATIC COLORECTAL CANCER
Clinical trials for UNRESECTABLE METASTATIC COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE METASTATIC COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for UNRESECTABLE METASTATIC COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immunotherapy combo shows promise against tough colorectal cancers
Disease control Recruiting nowThis study tests a new immunotherapy drug (STC-1010) combined with standard chemotherapy for people with advanced colorectal cancer that cannot be removed by surgery. The goal is to find a safe dose and see if it helps control the cancer longer. About 90 adults aged 18-75 will pa…
Matched conditions: UNRESECTABLE METASTATIC COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Brenus Pharma • Aim: Disease control
Last updated May 17, 2026 06:15 UTC
-
New drug trial offers hope for Hard-to-Treat gut cancers
Disease control Recruiting nowThis early-phase study tests an experimental drug called JNJ-89402638 in people with advanced colorectal or stomach cancer that has spread and not responded to prior treatments. The study will also test the drug combined with bevacizumab (with or without chemotherapy) for colorec…
Matched conditions: UNRESECTABLE METASTATIC COLORECTAL CANCER
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 12, 2026 13:39 UTC